After 51 years,pharmaceutical giant,GSK,turns back on Nigeria
…Runs from harsh economy By Onome Amuge. GlaxoSmithKline (GSK), a British multinational pharmaceutical and biotechnology company has
Nigeria not in list of beneficiaries for 18m doses malaria vaccine rollout
By Ben Eguzozie. Nigeria has been left out of a list of African countries slated to benefit from 18 million doses of malaria
Mutual Benefits, GSK, emerge worst performing stocks in April as 70 stocks trade flat
A decline in the share prices of 67 stocks listed on the Nigerian Stock Exchange (NSE) in the month of April led to a 0.57 percent dip